Safety, Immunogenicity, and Surrogate Markers of Clinical Efficacy for Modified Vaccinia Ankara as a Smallpox Vaccine in HIV-Infected Subjects

Evaluation of smallpox vaccines using variola neutralization

(2009) I. K. Damon et al.   JOURNAL OF GENERAL VIROLOGY

Modified vaccinia Ankara strains with identical coding sequences actually represent complex mixtures of viruses that determine the biological properties of each strain

(2009) Mark Suter et al.   VACCINE

A randomized, double-blind, dose-finding Phase II study to evaluate immunogenicity and safety of the third generation smallpox vaccine candidate IMVAMUNE®

(2009) Alfred von Krempelhuber et al.   VACCINE

Electrocardiography Screening for Cardiotoxicity after Modified Vaccinia Ankara Vaccination

(2008) Junko Sano et al.   AMERICAN JOURNAL OF MEDICINE

Severe Eczema Vaccinatum in a Household Contact of a Smallpox Vaccinee

(2008) Surabhi Vora et al.   CLINICAL INFECTIOUS DISEASES

IMVAMUNE®: modified vaccinia Ankara strain as an attenuated smallpox vaccine

(2008) Jeffrey S Kennedy et al.   Expert Review of Vaccines

Survival of lethal poxvirus infection in mice depends on TLR9, and therapeutic vaccination provides protection

(2008) Christofer Samuelsson et al.   JOURNAL OF CLINICAL INVESTIGATION

Rapid protection in a monkeypox model by a single injection of a replication-deficient vaccinia virus

(2008) P. L. Earl et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA